Patient Stories

HEAR FROM PEOPLE
WHO ARE TAKING BRIUMVI

HEAR FROM PEOPLE WHO ARE TAKING BRIUMVI

HEAR FROM PEOPLE WHO ARE TAKING BRIUMVI

People seated outdoors at a table together

People featured on this page are taking BRIUMVI and have been compensated by TG Therapeutics for their time.

People featured on this page are taking BRIUMVI and have been compensated by TG Therapeutics for their time.

These individual stories feature people who have taken BRIUMVI for their RMS – either as a first treatment or after trying other options. Hear why thousands of people, like Mandy, Alex and Meaghan, chose BRIUMVI to take on their RMS.

These individual stories feature people who have taken BRIUMVI for their RMS – either as a first treatment or after trying other options. Hear why thousands of people, like Mandy, Alex and Meaghan, chose BRIUMVI to take on their RMS.

Mandy, on the BRIUMVI dosing schedule

Danté, on BRIUMVI financial assistance

Taylor, on her journey from diagnosis to BRIUMVI

Alex, on why BRIUMVI was the right choice for him

Meaghan, on researching treatment options

Jules, on switching from once-a-day oral to BRIUMVI

See All Stories

Melanie, a person with RMS taking BRIUMVI® (ublituximab-xiiy)

Melanie

Categories: BRIUMVI as 1st treatment

My diagnosis came quick and left me feeling very confused. The onset of my first symptom to my official diagnosis happened in just over a month. I was losing my field of vision in my left eye and had a terrible headache that wasn’t going away. My vision loss was affecting my ability to work. The following day I was scheduled for an MRI and was scheduled to see a neurologist who specialized in MS. This was the first mention of Multiple Sclerosis, and it left me feeling confused and flooded with questions.

My doctor presented me with several treatment options and was interested in starting me on BRIUMVI, as she felt like it was a good option for me. I told her that I was going to do my research on these treatments, review the materials she gave me, and then discuss my options with her.

I was interested in starting BRIUMVI since it would be a twice-a-year infusion following the starting dose. I felt as though it wouldn’t interfere too much with my life or work schedule. Since starting BRIUMVI, my doctor feels like it’s working for me and that makes me happy.

I just want to say that no matter what your situation is, always advocate for yourself along your journey with MS. If you’re newly diagnosed, know that there is hope for a future!

 

 

Melanie

I enjoy hiking and biking around my local state park. I love going to concerts and spending time with friends. Before my RMS diagnosis, I was living an average life with my husband and two dogs and working full-time at a surgery center.

Maria, a person with RMS taking BRIUMVI® (ublituximab-xiiy)

Maria

Categories: BRIUMVI as 1st treatment

I was officially diagnosed with Relapsing Multiple Sclerosis in 2017 at the age of 48. Doctors have told me it’s likely I’ve had MS for years based on the lesions on an MRI. Looking back over the years, I recognize changes I went through that are typical of MS such as falling, exhaustion, muscle spasms, and listing to the left when I walk.

I found a neurologist, and he and the nurse sat with me for about an hour, and went over treatment options, including several clinical trials, one of which was for ublituximab (now known as BRIUMVI). We talked in detail about the trial. Knowing that I had the opportunity to participate in the trial and potentially help others, I was interested in trying it.

In April 2018, I had my first infusion. After the 2-year clinical trial and FDA approval, I had the option to continue BRIUMVI. I agreed to be part of the long-term study. I have been taking BRIUMVI for over 5 years and my doctor thinks I am doing well.

I am thankful for the work that TG Therapeutics has put into developing and testing BRIUMVI through the years. Many people at TG have had their lives touched by MS through the years by friends or family members who have MS. They are committed to a product accessible to people living with MS.

 

 

Maria

I’ve been married to my husband and best friend for over 20 years. We’ve never had any children, and we focused our time on volunteering with rescue dogs. Dogs have been a huge part of our lives since before we were married. We currently have two and they bring me such joy!

Linda, a person with RMS taking BRIUMVI® (ublituximab-xiiy)

Linda

Categories: BRIUMVI as 1st treatment

My official diagnosis of RMS occurred on a Friday in February. I was walking back to my work area at home when my entire right side went numb/heavy and my arm spasmed into my body. I could barely move and even the right side of my tongue went numb. The feeling lasted for less than a minute, and my first thought was, “that was weird,” but then the numbness and spasms kept happening sporadically, and I thought I was having a stroke. I went to the ER and immediately had a CAT scan. The attending doctor said it wasn’t a stroke and sent me to have a full set of MRIs, with and without contrast, for my head and upper and lower spine.

I had a video consultation with the on-call neurologist after he had received the results from the MRIs, and he told me that it was Relapsing MS. He said I had lesions on my brain and one on my brainstem. I was admitted to the hospital for treatment and observation. My youngest sister has MS, and one of my good friends was diagnosed with MS 10 years ago, so I knew it wasn’t the end of the world, just a realignment of what life would be like for me for the future.

I met with my neurologist and her team and we reviewed my diagnosis and treatment plan. They recommended BRIUMVI. I received my first dose of BRIUMVI at the end of April 2024. I have since had additional infusions and my doctor says that I am doing well.

While having a diagnosis of RMS isn’t ideal, I’m grateful my experience wasn’t as overwhelming and stressful as it could have been. I received an immediate referral from the on-call neurologist and within a short period of time, I started treatment. I’m extremely optimistic about the positive results from other patients receiving DMTs, including BRIUMVI. I continue to set travel plans throughout the year and I’m not going to let this diagnosis stop me from doing what I love to do (being outside and going to new places). I have confidence that I can still lead a full and adventurous life.

 

 

Linda

I’m a technical writing and editing supervisor for an environmental planning company, and to say I love my job is an understatement. I’m very outdoorsy and I hike as much as possible. I enjoy traveling and exploring new places. I’ve been to multiple other countries and have visited almost all of the 50 states.

Share your BRIUMVI story

Interested in sharing your BRIUMVI experience with others?

BRIUMVI Patient Support

Discover a flexible program designed to support the treatment journey.

BRIUMVI® (ublituximab-xiiy) Patient Support logo
Professional woman working on her laptop

Financial Assistance

No matter what type of health insurance you have, there may be support to help you afford BRIUMVI. Options may be available for you even if you have no health insurance at all. Learn about the potential options.

INDICATION AND IMPORTANT
SAFETY INFORMATION

Who should not receive BRIUMVI?

Do not receive BRIUMVI if you have an active hepatitis B virus (HBV) infection.

Do not receive BRIUMVI if you have had a life-threatening allergic reaction to BRIUMVI. Tell your healthcare provider if you have had an allergic reaction to BRIUMVI or any of its ingredients in the past.

What is the most important information I should know
about BRIUMVI?

BRIUMVI can cause serious side effects, including:

  • Infusion reactions: Infusion reactions are one of the most common side effects of BRIUMVI, which can be serious and may require you to be hospitalized. You will be monitored during your infusion and may be monitored after each infusion of BRIUMVI for signs and symptoms of an infusion reaction. Tell your healthcare provider if you get any of these symptoms:
    • fever
    • chills
    • headache
    • flu-like symptoms
    • fast heartbeat
    • hives
    • itchy skin
    • dizziness
    • feeling faint
    • swelling of tongue or throat
    • trouble breathing
    • wheezing
    • nausea
    • abdominal pain
    • throat irritation
    • redness of the face or skin

These infusion reactions can happen over 24 hours after your infusion. It is important that you call your healthcare provider right away if you get any of the signs or symptoms listed above after each infusion. If you get an infusion reaction, your healthcare provider may need to stop or slow down the rate of your infusion.

  • Infection:
    • Infections are a common side effect, and upper respiratory tract infections are one of the most common side effects of BRIUMVI. BRIUMVI increases your risk of getting infections caused by bacteria or viruses that may be life-threatening or cause death. Tell your healthcare provider if you have an infection or have any of the following signs of infection including fever, chills, a cough that does not go away, or painful urination. Your healthcare provider should delay your treatment with BRIUMVI until your infection is gone.
    • Hepatitis B virus (HBV) reactivation: Before starting treatment with BRIUMVI, your healthcare provider will do blood tests to check for hepatitis B viral infection. If you have ever had hepatitis B virus infection, the hepatitis B virus may become active again during or after treatment with BRIUMVI. Hepatitis B virus becoming active again (called reactivation) may cause serious liver problems including liver failure or death. Your healthcare provider will monitor you if you are at risk for hepatitis B virus reactivation during treatment and after you stop receiving BRIUMVI.
    • Weakened immune system: BRIUMVI taken before or after other medicines that weaken the immune system could increase your risk of getting infections.
    • Progressive Multifocal Leukoencephalopathy (PML): PML is a rare, serious brain infection caused by a virus that may get worse over days or weeks. PML can result in death or severe disability. PML has been reported with BRIUMVI. Tell your healthcare provider right away if you have any new or worsening neurologic signs or symptoms. These symptoms may include weakness on one side of your body, loss of coordination in arms and legs, vision problems, changes in thinking and memory which may lead to confusion, and personality changes.
  • Low immunoglobulins: BRIUMVI may cause a decrease in some types of antibodies. Your healthcare provider will do blood tests to check your blood immunoglobulin levels.

Before receiving BRIUMVI, tell your healthcare provider about all of your medical conditions, including if you:

  • have or think you have an infection.
  • take or plan to take medicines that affect your immune system. These medicines may increase your risk of getting an infection.
  • have ever had hepatitis B or are a carrier of the hepatitis B virus.
  • have a history of liver problems.
  • have had a recent vaccination or are scheduled to receive any vaccinations.
    • You should receive any required ‘live’ or ‘live-attenuated’ vaccines at least 4 weeks before you start treatment with BRIUMVI. You should not receive ‘live’ or ‘live-attenuated’ vaccines while you are being treated with BRIUMVI and until your healthcare provider tells you that your immune system is no longer weakened.
    • When possible, you should receive any ‘non-live’ vaccines at least 2 weeks before you start treatment with BRIUMVI. If you would like to receive any non-live vaccines while you are being treated with BRIUMVI, talk to your healthcare provider.
    • If you have a baby and you received BRIUMVI during your pregnancy, it is important to tell your baby’s healthcare provider about receiving BRIUMVI so they can decide when your baby should be vaccinated.
  • are pregnant, think that you might be pregnant, or plan to become pregnant. It is not known if BRIUMVI will harm your unborn baby. You should use birth control (contraception) during treatment with BRIUMVI and for at least 6 months after your last infusion of BRIUMVI. Talk with your healthcare provider about what birth control method is right for you during this time.
  • are breastfeeding or plan to breastfeed. It is not known if BRIUMVI passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take BRIUMVI.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of BRIUMVI?

BRIUMVI may cause serious side effects, including:

• See “What is the most important information I should know about BRIUMVI?”

Liver damage. BRIUMVI may cause liver damage. Your healthcare provider will do blood tests to check your liver before you start BRIUMVI and while you take BRIUMVI if needed. Tell your healthcare provider right away if you have any symptoms of liver damage, such as:

    • yellowing of the skin and eyes (jaundice)
    • nausea
    • vomiting
    • unusual darkening of the urine
    • feeling tired or weak

The most common side effects of BRIUMVI include:

  • Infusion reactions, upper and lower respiratory tract infections, herpes infections, extremity pain, insomnia, and fatigue.

These are not all the possible side effects of BRIUMVI. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to TG Therapeutics at 1-877-TGTXINC (1-877-848-9462).

For more important information, go to www.briumvi.com or call 1-833-BRIUMVI (1-833-274-8684).

Indication

BRIUMVI is a prescription medication used to treat adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapse-remitting disease, and active secondary progressive disease.

Stay in the know

Sign up to receive the latest updates and resources for BRIUMVI

Join us for a Multiple Sclerosis (MS) educational event near you

Important Safety Information
Who should not receive BRIUMVI?
  • Do not receive BRIUMVI if you have an active hepatitis B virus (HBV) infection.
  • Do not receive BRIUMVI if you have had a life-threatening allergic reaction to BRIUMVI. Tell your healthcare provider if you have had an allergic reaction to BRIUMVI or any of its ingredients in the past.
Indication
BRIUMVI is a prescription medication used to treat adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapse-remitting disease, and active secondary progressive disease.

Click or scroll to see IMPORTANT SAFETY INFORMATION AND INDICATION

Important Safety Information
Who should not receive BRIUMVI?
  • Do not receive BRIUMVI if you have an active hepatitis B virus (HBV) infection.
  • Do not receive BRIUMVI if you have had a life-threatening allergic reaction to BRIUMVI. Tell your healthcare provider if you have had an allergic reaction to BRIUMVI or any of its ingredients in the past.